Table 2.
Characteristics | |
---|---|
Systemic symptoms, n (%) | |
Cough | 7 (3.4) |
Rhinorrhea | 6 (2.9) |
Sore throat | 79 (38.5) |
Malaise | 123 (60.0) |
Fatigue | 105 (51.5) |
Back pain | 77 (37.6) |
Fever | 162 (79.0) |
Headache | 119 (58.1) |
Chills and sweats | 69 (33.8) |
Pruritus | 27 (13.2) |
Lymphadenopathies, n (%) | |
Any lymphadenopathy | 111 (54.2) |
Lymphadenopathy distribution | |
Localized | 98 (88.3) |
Generalized | 13 (11.7) |
Lymphadenopathy by region | |
Axilar | 2 (1.8) |
Cervical unilateral | 18 (16.2) |
Cervical bilateral | 22 (19.8) |
Inguinal unilateral | 34 (30.6) |
Inguinal bilateral | 29 (26.1) |
Submandibular | 2 (1.8) |
Rash or skin lesions at consultation, n (%) | |
Lesion distribution | |
Localized | 38 (18.6) |
Generalized | 166 (81.4) |
Lesion location | |
Face, head or neck | 128 (62.7) |
Trunk | 142 (69.3) |
Upper extremities | 111 (54.4) |
Lower extremities | 86 (41.9) |
Anogenital area | 160 (78.0) |
Lesion morphology | |
Macular | 116 (56.6) |
Papular | 162 (79.0) |
Vesicle | 44 (21.5) |
Pustule | 177 (86.3) |
Ulcer | 4 (2.0) |
Crust | 65 (31.7) |
Lesion pattern | |
Monomorphic | 31 (15.1) |
Polymorphic | 174 (84.9) |
Rash as first symptom identified | 94 (45.9) |
Time between last sexual encounter and onset of symptoms, days (median, IQR) | 7 (3 - 14) |
Time between onset of systemic symptoms and appearance of skin lesions, days (median, IQR) | 2 (1 - 4) |
Time between onset of symptoms and accessing the healthcare facility, days (mean, SD) | 6.7 ± 3.3 |
Started with systemic symptoms | 7.4 ± 3.2 |
Started with skin lesions | 5.9 ± 3.3 |
Had a sexual encounter while experiencing symptoms, n (%) | 44 (21.5) |
IQR, interquartile range.